Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARDELYX, INC.ARDX · Entity 4972 | Director | June 15, 2023 | June 16, 2023 |
| ELI LILLY & CoLLY · Entity 2794 | EVP,Science&Tech and Pres. LRL | February 09, 2018 | February 13, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARDELYX, INC.
Report date June 15, 2023 · Filed June 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 146,794 |
Reported balance
After 2023-06-15 transaction · row 1
1 source rowRow 1 · 2023-06-15 · Grant · Acquired 12,755 · Balance 146,794 F1: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.92 · Expires 2033-06-15 | Direct | 49,237 |
Reported balance
After 2023-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-15 · Grant · Acquired 49,237 · Balance 49,237 F2: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.
F2: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
F3: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
ELI LILLY & Co
Report date February 09, 2018 · Filed February 13, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2021-02-09 | Direct | 7,871 |
Reported balance
After 2018-02-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-09 · Grant · Acquired 7,871 · Balance 7,871 F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |
| Common StockSEC Table I · non-derivative | Direct | 198,126 |
Reported balance
Holding disclosure · report date 2018-02-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 198,126 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,086 |
Reported balance
Holding disclosure · report date 2018-02-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,086 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2023 Filed Jun 16, 2023 18:33 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 49,237 | $0.00 Strike: $3.92 | $0.00 |
DisclosureSEC source: 0001628280-23-022559 · wk-form4_1686954798.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,237 Underlying: Common Stock · 49,237 shares Expires 2033-06-15 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 18:33 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 12,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-022559 · wk-form4_1686954798.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,794 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:20 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001567619-22-013083 · doc1.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-06-15 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:20 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 91,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013083 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,039 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:08 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 32,765 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-21-012427 · doc1.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,765 Underlying: Common Stock · 32,765 shares Expires 2031-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:08 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 7,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012427 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,799 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 18:22 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 23,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001567619-20-012031 · doc1.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Underlying: Common Stock · 23,500 shares Expires 2030-06-09 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 18:22 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 6,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-012031 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,618 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 16:35 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001567619-19-013486 · doc1.xml · derivative · entry 2 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-06-13 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 16:35 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 17,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013486 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,121 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 18:55 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 11,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028859 · doc1.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,786 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 14:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001140361-18-015191 · doc1.xml · derivative · entry 1 Lundberg Jan M · CIK 0001480120 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-03-23 F1 · derivative.exercise_date: The option vests and becomes exercisable with respect to 1/36th of the shares subject to the option on each monthly anniversary of March 23, 2018, subject to the Reporting Person's continued service relationship with the Issuer through each such vesting date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 15:47 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 7,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000080 · wf-form4_151853685912764.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,871 Underlying: Common Stock · 7,871 shares Expires 2021-02-09 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:21 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 36,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000066 · wf-form4_151787287602417.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,252 shares Expires 2018-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:21 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 16,169 | $81.45 | $1,316,965.05 |
DisclosureSEC source: 0000059478-18-000066 · wf-form4_151787287602417.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,126 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 23:21 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 36,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000066 · wf-form4_151787287602417.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 22:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000033 · wf-form4_151743942666014.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 22:57 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 22,890 | $87.60 | $2,005,164.00 |
DisclosureSEC source: 0000059478-18-000033 · wf-form4_151743942666014.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,043 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,366 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 7,215 | $77.03 | $555,771.45 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,153 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:09 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 36,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000039 · wf-form4_148590415686193.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,252 Underlying: Common Stock · 36,252 shares Expires 2018-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 23:09 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 32,268 | $75.38 | $2,432,361.84 |
DisclosureSEC source: 0000059478-17-000039 · wf-form4_148590415686193.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,002 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 15,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,541 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 7,308 | $79.10 | $578,062.80 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,734 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 18:55 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 15,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000300 · wf-form4_145452573491445.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:47 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000271 · wf-form4_145402484078040.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,366 Underlying: Common Stock · 15,366 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:47 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 29,081 | $81.96 | $2,383,478.76 |
DisclosureSEC source: 0000059478-16-000271 · wf-form4_145402484078040.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,501 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 15:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,085 | $70.08 | $776,836.80 |
DisclosureSEC source: 0000059478-15-000078 · wf-form4_142323500599128.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,420 F1 · price: This transaction was executed in multiple trades at prices ranging from $70.01 to $70.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 03, 2015 Filed Feb 3, 2015 20:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 71,711 | $70.72 | $5,071,401.92 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,505 F2 · price: This transaction was executed in multiple trades at prices ranging from $70.50 to $71.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 02, 2015 Filed Feb 3, 2015 20:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 50,000 | $70.87 | $3,543,500.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,216 F1 · price: This transaction was executed in multiple trades at prices ranging from $70.74 to $71.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 20,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · derivative · entry 6 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,985 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 9,900 | $72.00 | $712,800.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,216 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 20:59 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 20,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000058 · wf-form4_142299717842271.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:24 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 15,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000030 · wf-form4_142265665197791.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,541 Underlying: Common Stock · 15,541 shares Expires 2016-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:24 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 44,073 | $70.97 | $3,127,860.81 |
DisclosureSEC source: 0000059478-15-000030 · wf-form4_142265665197791.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,131 Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 21,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000062 · wf-form4_139152760533600.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,552 shares Expires 2014-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 10,123 | $54.01 | $546,743.23 |
DisclosureSEC source: 0000059478-14-000062 · wf-form4_139152760533600.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,058 Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 21,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000062 · wf-form4_139152760533600.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2014 Filed Jan 31, 2014 01:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 20,985 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000027 · wf-form4_139113175999893.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,985 Underlying: Common Stock · 20,985 shares Expires 2015-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 28, 2014 Filed Jan 31, 2014 01:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 43,376 | $54.23 | $2,352,280.48 |
DisclosureSEC source: 0000059478-14-000027 · wf-form4_139113175999893.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,629 Read SEC document |
| March 12, 2013 Filed Mar 13, 2013 15:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,000 | $55.38 | $1,052,220.00 |
DisclosureSEC source: 0001209191-13-016142 · doc4.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,253 F1 · price: This transaction was executed in multiple trades at prices ranging from $55.33 to $55.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 33,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · derivative · entry 7 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Stock Units vests in three equal annual installments as follows: 33,333 on February 1, 2011; 33,333 on February 1, 2012; and 33,334 on February 1, 2013. F1 · derivative.expiration_date: The Restricted Stock Units vests in three equal annual installments as follows: 33,333 on February 1, 2011; 33,333 on February 1, 2012; and 33,334 on February 1, 2013. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 44,122 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · derivative · entry 6 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,122 shares Expires 2013-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 15,657 | $53.69 | $840,624.33 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · nonDerivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,253 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 33,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · nonDerivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 20,725 | $53.69 | $1,112,725.25 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,576 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 44,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005985 · doc4.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 22:04 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 21,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005015 · doc4.xml · derivative · entry 3 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,552 Underlying: Common Stock · 21,552 shares Expires 2014-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 22:04 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 44,832 | $53.21 | $2,385,510.72 |
DisclosureSEC source: 0001209191-13-005015 · doc4.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,179 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.